{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:49:27Z","timestamp":1782121767971,"version":"3.54.5"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:p>\n                    Hypertensionis one of the leading causes of cardiovascular disease and premature death worldwide, affecting more than 1.2 billion adults, with a significant part living in low- and middle-income countries. Pediatric hypertension is also a growing concern, with an estimated 4.5% of children in the United States affected. The 2024 European Society of Cardiology guidelines provide updated protocols for diagnosing and treating hypertension in adults, while pediatrics diagnosis is based on age and weight-specific percentiles. The renin-angiotensin-aldosterone system plays a crucial role in blood pressure (BP) regulation, with 2 pathways: classical pathway and alternative pathway. classical pathway increases BP and fluid retention, while alternative pathway counteracts these effects. Neuropeptides such as Nesfatin-1 (Nes-1) and Galanin (Gal), along with the endocannabinoid system, also influence BP regulation. The study focused on adolescents with hypertension, obesity, or combination. From the hospital, 128 patients were recruited to the study. Plasma samples were analyzed for Nes-1, Gal, anandamide (AEA), and 2-arachidonoylglycerol levels. The results showed significantly lower levels of Nes-1 and Gal in the obese hypertensive patients (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.005 and\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.022 respectively) and obesity groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.022 and\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.035 respectively) compared to the controls. AEA levels did not show significant differences, while 2-arachidonoylglycerol levels were tendential to higher concentration in hypertensive patients. The lower concentration of Nes-1 and Gal can be considered as predictive factors of hypertension in obese patients, with Nes-1 negatively correlated with systolic pressure. Endocannabinoid system, through cannabinoid receptors 1, may also influence BP, though its role requires further research. Understanding these systems could improve the management of hypertension, particularly in pediatric populations.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048609","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:00:42Z","timestamp":1777629642000},"page":"e48609","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Neuropeptides and endocannabinoid system as regulators of blood pressure in adolescents with primary hypertension"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-1493","authenticated-orcid":false,"given":"Adrian","family":"Martyniak","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Malopolska, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"W\u00f3jcicka","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Malopolska, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Dro\u017cd\u017c","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology and Hypertension, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Malopolska, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw J.","family":"Tomasik","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Malopolska, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-20260622","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2024.05.033","article-title":"2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension.","volume":"126","author":"Kreutz","year":"2024","journal-title":"Eur J Intern Med"},{"key":"R4-20260622","first-page":"e13","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"R5-20260622","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","article-title":"2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents.","volume":"34","author":"Lurbe","year":"2016","journal-title":"J Hypertens"},{"key":"R6-20260622","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","article-title":"Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies.","volume":"94","author":"Patel","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"R7-20260622","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/diagnostics13010016","article-title":"A new perspective on the renin-angiotensin system.","volume":"13","author":"Martyniak","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R8-20260622","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12576-019-00679-4","article-title":"Renin-angiotensin system research: from molecules to the whole body.","volume":"69","author":"Takimoto-Ohnishi","year":"2019","journal-title":"J Physiol Sci"},{"key":"R9-20260622","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1753944715599875","article-title":"Angiotensin-(1-7): beyond its central effects on blood pressure.","volume":"9","author":"Gironacci","year":"2015","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"R10-20260622","first-page":"57","article-title":"Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome.","volume":"15","author":"Sahin","year":"2015","journal-title":"Bosn J Basic Med Sci"},{"key":"R11-20260622","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mce.2015.01.012","article-title":"Endocannabinoid-mediated modulation of Gq\/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.","volume":"403","author":"Szekeres","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"R12-20260622","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cca.2021.08.005","article-title":"Nesfatin-1 in lipid metabolism and lipid-related diseases.","volume":"522","author":"Luo","year":"2021","journal-title":"Clin Chim Acta"},{"key":"R13-20260622","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2174\/1381612823666170130154407","article-title":"Metabolic and cardiovascular actions of nesfatin-1: implications in health and disease.","volume":"23","author":"Ramesh","year":"2017","journal-title":"Curr Pharm Des"},{"key":"R14-20260622","doi-asserted-by":"crossref","first-page":"170719","DOI":"10.1016\/j.peptides.2021.170719","article-title":"Interactions between nesfatin-1 and the autonomic nervous system-An overview.","volume":"149","author":"Rupp","year":"2022","journal-title":"Peptides"},{"key":"R15-20260622","doi-asserted-by":"crossref","first-page":"740174","DOI":"10.3389\/fendo.2021.740174","article-title":"Nesfatin-1 receptor: distribution, signaling and increasing evidence for a G protein-coupled receptor - A systematic review.","volume":"12","author":"Rupp","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R16-20260622","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5152\/eurasianjmed.2019.18420","article-title":"Regulatory peptide Nesfatin-1 and its relationship with metabolic syndrome.","volume":"51","author":"Tekin","year":"2019","journal-title":"Eurasian J Med"},{"key":"R17-20260622","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1210\/en.2011-1500","article-title":"Minireview: nesfatin-1--an emerging new player in the brain-gut, endocrine, and metabolic axis.","volume":"152","author":"Stengel","year":"2011","journal-title":"Endocrinology"},{"key":"R18-20260622","doi-asserted-by":"crossref","first-page":"100801","DOI":"10.1016\/j.yfrne.2019.100801","article-title":"Galanin peptide family regulation of glucose metabolism.","volume":"56","author":"Fang","year":"2020","journal-title":"Front Neuroendocrinol"},{"key":"R19-20260622","first-page":"183","article-title":"Galanin and epilepsy.","volume":"102","author":"Lerner","year":"2010","journal-title":"Exp Suppl"},{"key":"R20-20260622","first-page":"195","article-title":"Galanin and addiction.","volume":"102","author":"Picciotto","year":"2010","journal-title":"Exp Suppl"},{"key":"R21-20260622","first-page":"639","article-title":"Galanin in the regulation of the hypothalamic-pituitary-adrenal axis (Review).","volume":"19","author":"Tortorella","year":"2007","journal-title":"Int J Mol Med"},{"key":"R22-20260622","doi-asserted-by":"crossref","first-page":"170918","DOI":"10.1016\/j.peptides.2022.170918","article-title":"Cardioprotective effects of neuropeptide galanin: focusing on its roles against diabetic heart.","volume":"159","author":"She","year":"2023","journal-title":"Peptides"},{"key":"R23-20260622","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0167-0115(96)00127-9","article-title":"The effect of galanin and galanin fragments on blood pressure in the Cane toad, Bufo marinus.","volume":"67","author":"Mahns,","year":"1996","journal-title":"Regul Pept"},{"key":"R24-20260622","doi-asserted-by":"crossref","first-page":"102021","DOI":"10.1016\/j.npep.2020.102021","article-title":"Superoxide anions modulate the effects of alarin in the paraventricular nucleus on sympathetic activity and blood pressure in spontaneously hypertensive rats.","volume":"80","author":"Wang","year":"2020","journal-title":"Neuropeptides"},{"key":"R25-20260622","doi-asserted-by":"crossref","first-page":"175904","DOI":"10.1016\/j.ejphar.2023.175904","article-title":"Galanin receptors modulate cutaneous vasodilation elicited by whole-body and local heating but not thermal sweating in young adults.","volume":"954","author":"Fujii","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"R26-20260622","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.neuropharm.2004.12.005","article-title":"Blood pressure regulation by endocannabinoids and their receptors.","volume":"48","author":"Pacher","year":"2005","journal-title":"Neuropharmacology"},{"key":"R27-20260622","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/bs.apha.2017.05.002","article-title":"Cannabinoids in the Cardiovascular System.","volume":"80","author":"Ho","year":"2017","journal-title":"Adv Pharmacol"},{"key":"R28-20260622","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00210-004-1003-9","article-title":"Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.","volume":"371","author":"Pfitzer","year":"2005","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R29-20260622","doi-asserted-by":"crossref","first-page":"1098725","DOI":"10.3389\/fimmu.2022.1098725","article-title":"Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets.","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"R30-20260622","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/biomedicines12030620","article-title":"Classical and alternative pathways of the renin-angiotensin-aldosterone system in regulating blood pressure in hypertension and obese adolescents.","volume":"12","author":"Martyniak","year":"2024","journal-title":"Biomedicines"},{"key":"R31-20260622","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4274\/jcrpe.galenos.2019.2019.0072","article-title":"Can Nesfatin-1 Predict Hypertension in Obese Children?","volume":"12","author":"G\u00fcne\u015f","year":"2020","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"R32-20260622","doi-asserted-by":"crossref","first-page":"e12567","DOI":"10.1111\/ijpo.12567","article-title":"Sex-specific association of plasma nesfatin-1 concentrations with obesity in children.","volume":"14","author":"de Dios","year":"2019","journal-title":"Pediatr Obes"},{"key":"R33-20260622","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1684\/ecn.2020.0444","article-title":"Serum levels of nesfatin-1 and irisin in obese children.","volume":"31","author":"Dokumacioglu","year":"2020","journal-title":"Eur Cytokine Netw"},{"key":"R34-20260622","first-page":"189","article-title":"The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children.","volume":"14","author":"Abaci","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"R35-20260622","doi-asserted-by":"crossref","first-page":"e15460","DOI":"10.1097\/MD.0000000000015460","article-title":"The relation of serum nesfatin-1 level with anthropometric and metabolic parameters in children and adolescents: a prospective observational study.","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R36-20260622","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40618-016-0529-2","article-title":"Low levels of plasma galanin in obese subjects with hypertension.","volume":"40","author":"Fang","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"R37-20260622","doi-asserted-by":"crossref","first-page":"79","DOI":"10.36740\/WLek202201115","article-title":"Galanin levels in hypertensive patients with obesity.","volume":"75","author":"Kravchun","year":"2022","journal-title":"Wiad Lek"},{"key":"R38-20260622","first-page":"560","article-title":"Positive correlation of galanin with insulin resistance and triglyceride levels in obese children.","volume":"48","author":"Acar","year":"2018","journal-title":"Turk J Med Sci"},{"key":"R39-20260622","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.advms.2020.12.003","article-title":"Central nervous system, peripheral and hemodynamic effects of nanoformulated anandamide in hypertension.","volume":"66","author":"Mart\u00edn Gim\u00e9nez","year":"2021","journal-title":"Adv Med Sci"},{"key":"R40-20260622","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/pharmaceutics15010176","article-title":"Polymeric nanomicelles loaded with anandamide and their renal effects as a therapeutic alternative for hypertension treatment by passive targeting.","volume":"15","author":"Mart\u00edn Gim\u00e9nez","year":"2023","journal-title":"Pharmaceutics"},{"key":"R41-20260622","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejphar.2008.11.061","article-title":"Effects of hypertension on vasorelaxation to endocannabinoids in vitro.","volume":"603","author":"Wheal","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"R42-20260622","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/1440-1681.12450","article-title":"Enhanced vasorelaxation effect of endogenous anandamide on thoracic aorta in renal vascular hypertension rats.","volume":"42","author":"Guo","year":"2015","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R43-20260622","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1038\/s41598-022-09902-6","article-title":"Acute and long-term effects of cannabinoids on hypertension and kidney injury.","volume":"12","author":"Golosova","year":"2022","journal-title":"Sci Rep"},{"key":"R44-20260622","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/01.CIR.0000143230.23252.D2","article-title":"Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.","volume":"110","author":"B\u00e1tkai","year":"2004","journal-title":"Circulation"},{"key":"R45-20260622","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00005344-200304000-00020","article-title":"Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle.","volume":"41","author":"Bonz","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"R46-20260622","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2826.2008.01677.x","article-title":"Endocannabinoids, blood pressure and the human heart.","volume":"20","author":"Sarzani","year":"2008","journal-title":"J Neuroendocrinol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T09:09:44Z","timestamp":1782119384000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":44,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048609","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"2025-07-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}